-
101
-
102
Correction of Thrombocytopenia before Elective Surgery / Invasive Procedures in Patients with Liver Cirrhosis (Experts’ Agreement)
Published 2024-08-01“…The Russian Scientific Liver Society selected a panel of experts in the field of therapeutic and surgical hepatology, hematology, transfusion medicine to make reasoned statements and recommendations on the issue of treatment of thrombocytopenia before elective surgery / invasive procedures in patients with liver cirrhosis.Results. …”
Get full text
Article -
103
Plant-nanoparticles enhance anti-PD-L1 efficacy by shaping human commensal microbiota metabolites
Published 2025-02-01Get full text
Article -
104
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States
Published 2025-02-01“…Richard S Finn,1 Renuka Iyer,2 Richard S Kalman,3 Neehar D Parikh,4 Roniel Cabrera,5 Svetlana Babajanyan,6 Ahmed O Kaseb7 1Department of Medicine, University of California, Los Angeles, CA, USA; 2Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA; 3Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA; 4Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA; 5Department of Medicine, University of Florida Health, Gainesville, FL, USA; 6US Medical Affairs, Oncology, Bayer Healthcare, Whippany, NJ, USA; 7Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence: Richard S Finn, Department of Medicine, University of California, Los Angeles, CA, USA, Tel +1-310-586-2091, Email [email protected]: While several systemic therapies are available for unresectable hepatocellular carcinoma (uHCC), there is a lack of granular real-world evidence to support the efficacy and safety of these therapies. …”
Get full text
Article -
105
-
106
Ginsenoside Rg1: A bioactive therapeutic agent for diverse liver diseases
Published 2025-02-01“…To delay the transition from benign tissue lesions to a substantial organ injury, scientists have gradually applied natural compounds derived from plants as a complementary therapy in the field of hepatology. Ginseng (Panax ginseng C. A. Meyer) is a tonic traditional Chinese herbal medicine, and natural products, including ginsenoside Rg1 (G-Rg1), which is a kind of 20(S)-protopanaxatriol saponin with a relatively high biological activity, can be isolated from the roots or stems of ginseng. …”
Get full text
Article -
107
-
108
Lipids in parenteral nutrition – expert consensus statements: Translating guidelines into clinical practice
Published 2025-04-01Get full text
Article -
109
-
110
Structure of Patients with Hepatocellular Cancer (Data Analysis from Two Specialised Centres)
Published 2020-05-01“…A retrospective analysis of the medical records of hepatological patients who sought medical treatment at to the V.Kh. …”
Get full text
Article -
111
-
112
-
113
-
114
Sex disparity in the association between alcohol consumption and sarcopenia: a population-based study
Published 2025-02-01Get full text
Article -
115
-
116
-
117
-
118
Liver Damage in Type 1 Diabetes Mellitus
Published 2021-06-01“…An up-to-date review of the prevalence, pathogenesis, diagnosis and management of hepatological complications of type 1 diabetes mellitus (T1D).Key points. …”
Get full text
Article -
119
Pegilated interferon α2а in treatment of chronic hepatitis C
Published 2012-09-01“…Follow-up of CHC patients, treated by pegIFN-α2а and ribavirin in the Moscow regional hepatological center, testifies its high efficacy and safety profile.…”
Get full text
Article -
120
Urinary tract infections in patients with decompensated liver cirrhosis, listed for liver transplantation
Published 2018-08-01“…The study included patients with liver cirrhosis Child Pugh class B and C with indications for liver transplantation, who were hospitalized at Sverdlovsk Regional hepatological center for liver disease decompensation in 2015 (n=137). …”
Get full text
Article